A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...
4don MSN
Reform of federal drug discount program should target misaligned incentives, researchers say
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.
Several recent policy proposals are placing new pressures on the 340B drug pricing program, a decades-old federal initiative many hospitals and health systems depend on to offset the costs of care for ...
In Oklahoma, three Planned Parenthood health centers are listed as participating in the 340B program as family planning clinics.
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily ...
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s ...
The core problem in 340B runs deeper than poor oversight. The law requires steep discounts for purchased drugs but does not specify that the savings should be passed on to patients and insurance ...
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. A major pharmaceutical company is reigniting ...
A federal judge on Tuesday refused to block Maine from enforcing a new state law requiring drugmakers to offer discounts on ...
One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...
A growing number of urban hospitals are reclassifying themselves as both urban and rural to reap financial benefits Congress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback